Zobrazeno 1 - 10
of 119
pro vyhledávání: '"A I, Riker"'
Autor:
Nikki Higa, Lisa Welter, Liya Xu, Anand Kolatkar, Kelli S. Bramlett, Ole V. Gjoerup, Ryon Graf, Richard S.P. Huang, Rebecca J. Leary, Young Lee, Jeremy G. Perkins, Adam I. Riker, Angad P. Singh, Lorraine Tafra, Carol K. Tweed, Craig D. Shriver, James Hicks, Peter Kuhn
Publikováno v:
Journal of Molecular Pathology, Vol 5, Iss 2, Pp 199-214 (2024)
The chief goal of the Blood Profiling Atlas in Cancer (BloodPAC) consortium is to promote collaborative efforts that support the development and implementation of liquid biopsy tests. Here, we report the results of a pilot study conducted by three Bl
Externí odkaz:
https://doaj.org/article/6ae858977c2d43baa452f6474dd156e7
Autor:
Hongyou Zhao, Bin Yi, Zhipin Liang, Ches’Nique Phillips, Hui-Yi Lin, Adam I. Riker, Yaguang Xi
Publikováno v:
Genes and Diseases, Vol 8, Iss 3, Pp 320-330 (2021)
Sulindac has shown significant clinical benefit in preventing colorectal cancer progression, but its mechanism of action has not been fully elucidated. We have found that sulindac sulfide (SS) is able to inhibit cell cycle progression in human colore
Externí odkaz:
https://doaj.org/article/1a38f7c488e84744aaeaebdee57d21a7
Autor:
Margarite D. Matossian, Alexandra A. Giardina, Maryl K. Wright, Steven Elliott, Michelle M. Loch, Khoa Nguyen, Arnold H. Zea, Frank H. Lau, Krzysztof Moroz, Adam I. Riker, Steven D. Jones, Elizabeth C. Martin, Bruce A. Bunnell, Lucio Miele, Bridgette M. Collins-Burow, Matthew E. Burow
Publikováno v:
Women's Health Reports, Vol 1, Iss 1, Pp 383-392 (2020)
Despite a decline in overall incidence rates for cancer in the past decade, due in part to impressive advancements in both diagnosis and treatment, breast cancer (BC) remains the leading cause of cancer-related deaths in women. BC alone accounts for
Externí odkaz:
https://doaj.org/article/68c5571fd2024721a83ad7f161d55ff0
Autor:
Tiffany C Chang, Margarite D Matossian, Steven Elliott, Hope E Burks, Rachel A Sabol, Deniz A Ucar, Henri Wathieu, Jovanny Zabaleta, Luis Del Valle, Sukhmani Gill, Elizabeth Martin, Adam I Riker, Lucio Miele, Bruce A Bunnell, Matthew E Burow, Bridgette M Collins-Burow
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0251106 (2021)
[This corrects the article DOI: 10.1371/journal.pone.0226464.].
Externí odkaz:
https://doaj.org/article/af0fed20a0a946dba307bf3dd7112a62
Autor:
Tiffany C Chang, Margarite D Matossian, Steven Elliott, Hope E Burks, Rachel A Sabol, Deniz A Ucar, Henri Wathieu, Jovanny Zabaleta, Luis Del Valle, Sukhmani Gill, Elizabeth Martin, Adam I Riker, Lucio Miele, Bruce A Bunnell, Matthew E Burow, Bridgette M Collins-Burow
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0226464 (2020)
Metaplastic breast carcinoma (MBC) is a clinically aggressive and rare subtype of breast cancer, with similar features to basal-like breast cancers. Due to rapid growth rates and characteristic heterogeneity, MBC is often unresponsive to standard che
Externí odkaz:
https://doaj.org/article/8167b126290f4ef29efb642a847dccf8
Publikováno v:
Ochsner Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3cfd619fe4815adc94f754b6b1aad35
https://doi.org/10.31486/toj.22.0120
https://doi.org/10.31486/toj.22.0120
Autor:
Yaguang Xi, Adam I. Riker, Augusto C. Ochoa, Li Li, Qingzhao Yu, Dorota Wyczechowska, Hao Cheng, Bin Yi
Immune-checkpoint inhibitor (ICI) therapy has been widely used to treat different human cancers, particularly advanced solid tumors. However, clinical studies have reported that ICI immunotherapy benefits only ∼15% of patients with colorectal cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cfaee94669efd8ac6214cd9bf921f5a
https://doi.org/10.1158/1535-7163.c.6543553
https://doi.org/10.1158/1535-7163.c.6543553
Autor:
Yaguang Xi, Adam I. Riker, Augusto C. Ochoa, Li Li, Qingzhao Yu, Dorota Wyczechowska, Hao Cheng, Bin Yi
Supplementary figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7659891a2d487666629536e0d835acc1
https://doi.org/10.1158/1535-7163.22523017.v1
https://doi.org/10.1158/1535-7163.22523017.v1
Autor:
James W. Orr, Ann M. Thompson, Dennis Bruens, Jennifer Higgins, Yvonne Rittenhouse, Mark Bloomston, Adam I. Riker
Publikováno v:
The Ochsner journal. 22(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc41ba8c84030e308c2a4207f22c5a7b
https://pubmed.ncbi.nlm.nih.gov/36189098
https://pubmed.ncbi.nlm.nih.gov/36189098
Autor:
Augusto C. Ochoa, E F Cromwell, H Brown, Elizabeth C. Martin, O Sirenko, Krzysztof Moroz, Matthew E. Burow, A M Ham, Katherine Hebert, S Sinha, Erik F. Flemington, Jovanny Zabaleta, Hope E. Burks, Jacob Bursavich, Margarite D. Matossian, A I Riker, Steven Elliott, Bridgette M. Collins-Burow, Khoa Nguyen, Maryl K. Wright, Gabrielle O. Windsor, Frank H. Lau, Connor T. King, Henri Wathieu, Reza Izadpanah, Melody Baddoo, Madlin Alzoubi, Arnold H. Zea, Tiffany R. Chang, Lucio Miele, Rachel A. Sabol, Bruce A. Bunnell, J J Savoie
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Metaplastic breast carcinoma (MBC) is a rare breast cancer subtype with rapid growth, high rates of metastasis, recurrence and drug resistance, and diverse molecular and histological heterogeneity. Patient-derived xenografts (PDXs) provide a translat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7608096d198218e92f3849a83769035
https://doi.org/10.1007/s12094-021-02677-8
https://doi.org/10.1007/s12094-021-02677-8